Latest News

Oklahoma's case turns emotional in opioid trial vs. Johnson & Johnson

By John Sammon | Jun 19, 2019

NORMAN, Okla. (Legal Newsline) – A Connecticut businessman recounting the heartbreak of his son’s death from drug addiction on Tuesday outlined steps to end the stigma of the disease and to make treatment improvements in a trial to determine if Johnson & Johnson helped cause a prescription opioid epidemic.

At opioid trial, Johnson & Johnson moves to strike Oklahoma witness as 'de facto member of State's legal team'

By Dan Fisher | Jun 18, 2019

NORMAN, Okla. (Legal Newsline) - Johnson & Johnson has asked the judge overseeing the first in an expected wave of trials against the opioid industry to strike the testimony of Dr. Andrew Kolodny, a psychiatrist who plays a central role in the State of Oklahoma’s case by linking narcotics marketing to opioid addiction and overdose deaths.

J&J's lawyers note opioids researcher being paid hundreds of thousands for testimony in Oklahoma trial

By John Sammon | Jun 18, 2019

NORMAN, Okla. (Legal Newsline) – Attorneys defending Johnson & Johnson on Monday fended off accusations their client caused an addiction crisis and shifted attention onto Purdue Pharma, while also noting a plaintiffs expert is being paid upward of $500,000 for his testimony.

Oklahoma's governor is worried AG Hunter won't turn $85M opioid settlement over to treasury

By John Sammon | Jun 18, 2019

NORMAN, Okla. (Legal Newsline) – Oklahoma Gov. Kevin Stitt and two high-ranking lawmakers fear that funds from a recent opioid settlement won't head their way and are asking to intervene, claiming Attorney General Mike Hunter's recent $85 million agreement with Teva Pharmaceutical might violate a new state law.

Witness list offers a preview of arguments to come in Oklahoma's big opioid trial

By Kayla Elder | Jun 17, 2019

NORMAN, Okla. (Legal Newsline) – Not all named witnesses will be called to testify in the two-month-long trial that is beginning its fourth week in Cleveland County Court - a trial that pits the State of Oklahoma against Johnson & Johnson over the abatement of what Oklahoma calls a man-made opioid crisis - but 10 of the more than 160 listed overlap the sides.

Attorneys for J&J spar with opioids researcher over warning labels during Oklahoma trial

By John Sammon | Jun 17, 2019

NORMAN, Okla. (Legal Newsline) – Attorneys for Johnson & Johnson on Friday during questioning of a researcher called as a witness by the State attempted to establish that the company’s production of opioid drugs was a government-regulated process with detailed warnings of possible addiction provided.

Opioid lawyers propose a global settlement team; Pa. attorney critical, says it's likely a ploy to boost their fees

By Daniel Fisher | Jun 15, 2019

CLEVELAND (Legal Newsline) - Acknowledging it is “likely impossible” to negotiate individual settlements on behalf the nearly 2,000 cities and counties suing the opioid industry, plus thousands more watching from the sidelines, plaintiff lawyers have proposed a unique solution: A “negotiation class” designed to strike a global bargain on behalf of every municipality in the country.

J&J finally gets chance to question opioids researcher during Oklahoma trial, fights 'kingpin' remark

By John Sammon | Jun 14, 2019

NORMAN , Okla. (Legal Newsline) – On his third day of testimony, an opioids researcher was cross-examined by attorneys for Johnson & Johnson as the company defends itself from allegations that it is to blame for the nation's addiction crisis.

'It keeps changing': Oklahoma's opioid strategy is a 700-year-old English law that used to regulate wandering sheep

By Daniel Fisher | Jun 13, 2019

NORMAN, Okla. (Legal Newsline) - The opioid trial now underway in a county courthouse in Oklahoma offers the first look at a legal strategy that could result in tens of billions of dollars in liability against the manufacturers and distributors of addictive narcotic painkillers in similar lawsuits nationwide.

Oklahoma witness in opioid trial says drug users not to blame for addiction crisis

By John Sammon | Jun 13, 2019

NORMAN, Okla. (Legal Newsline) – During a second day of testimony, an opioid researcher questioned by private attorneys hired by the State of Oklahoma said opioid sellers like Johnson & Johnson sought to shift blame for a prescription drug epidemic onto those not responsible.

Marketing of J&J's opioids discussed at Oklahoma's big trial

By John Sammon | Jun 11, 2019

NORMAN, Okla. (Legal Newsline) – A marketing specialist told attorneys for the State of Oklahoma on Monday that the rise in the sales of opioid drugs could be tied to a similar rise over the same period from 1996 to 2017 to deaths from overdose.

Okla. AG's lawyers offer testimony of addict in big opioid trial, but witness said he never used J&J's products

By John Sammon | Jun 10, 2019

NORMAN, Okla. (Legal Newsline) – A resident of this small Oklahoma town recounted the hell of his addiction to opioid drugs that began with a legal prescription and then spiraled out of control, testifying in a lawsuit accusing Johnson & Johnson of causing a drug epidemic.

Oklahoma's hired guns continue to portray Johnson & Johnson as evil to judge in opioid trial

By John Sammon | Jun 6, 2019

NORMAN, Okla. (Legal Newsline) – On Wednesday, private attorneys hired by the State of Oklahoma on a contingency fee accused Janssen Pharmaceuticals, the drug arm of Johnson & Johnson, of ignoring the warning signs of a nationwide addiction crisis in order to maximize profit.

In high-profile opioid trial, Johnson & Johnson reminds that its addiction warnings were approved by the FDA

By John Sammon | Jun 5, 2019

NORMAN, Okla. (Legal Newsline) – Defense attorneys for Johnson & Johnson took over the questioning of Kimberly Deem-Eshleman, southeast regional business director for Janssen Pharmaceuticals and the marketer of its opioid drug Nucynta, attempting to establish that drug labels had provided plenty of warnings about possible addiction.

Janssen exec questioned for third day by Oklahoma's hired guns in big opioid trial

By John Sammon | Jun 3, 2019

NORMAN, Okla. (Legal Newsline) – In the closely watched opioid trial taking place in Oklahoma, private attorneys representing the State on Monday sought to portray Johnson & Johnson and its drug subsidiary Janssen Pharmaceuticals as marketing drugs like Nucynta for profit in order to feed an opioid epidemic they ignored.

The Record Network